128 related articles for article (PubMed ID: 37598866)
1. Clinical impact of pancreatic steatosis measured by CT on the risk of post-ERCP pancreatitis: a multicenter prospective trial.
Chung MJ; Park SW; Lee KJ; Park DH; Koh DH; Lee J; Lee HS; Park JY; Bang S; Min S; Park JH; Kim SJ; Park CH
Gastrointest Endosc; 2024 Feb; 99(2):214-223.e4. PubMed ID: 37598866
[TBL] [Abstract][Full Text] [Related]
2. Impact of pancreatic fat on the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis.
Park CH; Chung MJ; Park DH; Min S; Park SW
Surg Endosc; 2022 Aug; 36(8):5734-5742. PubMed ID: 35099627
[TBL] [Abstract][Full Text] [Related]
3. Early pancreatic stent placement in wire-guided biliary cannulation: A multicenter retrospective study.
Hakuta R; Hamada T; Nakai Y; Isayama H; Kogure H; Takahara N; Mizuno S; Yagioka H; Togawa O; Matsubara S; Ito Y; Yamamoto N; Tada M; Koike K
J Gastroenterol Hepatol; 2019 Jun; 34(6):1116-1122. PubMed ID: 30152138
[TBL] [Abstract][Full Text] [Related]
4. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic temporary 3F pancreatic duct stent to prevent post-ERCP pancreatitis in patients with a difficult biliary cannulation: a multicenter, prospective, randomized study.
Lee TH; Moon JH; Choi HJ; Han SH; Cheon YK; Cho YD; Park SH; Kim SJ
Gastrointest Endosc; 2012 Sep; 76(3):578-85. PubMed ID: 22771100
[TBL] [Abstract][Full Text] [Related]
6. Analysis of risk factors and prevention strategies of post-ERCP pancreatitis.
Lin Y; Liu X; Cao DQ; Tang JH; Wen JJ; Li TF; Liu PF; Xia TS
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5185-5190. PubMed ID: 29228432
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic pancreatic stent placement and post-ERCP pancreatitis: an updated meta-analysis.
Mazaki T; Mado K; Masuda H; Shiono M
J Gastroenterol; 2014 Feb; 49(2):343-55. PubMed ID: 23612857
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of strategies for preventing post-ERCP pancreatitis after early precut sphincterotomy for biliary access.
Ang TL; Kwek AB; Song M; Li JW; Thurairajah PH
J Dig Dis; 2016 Oct; 17(10):692-696. PubMed ID: 27556283
[TBL] [Abstract][Full Text] [Related]
9. Nafamostat Mesylate is Not Effective in Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.
Matsumoto T; Okuwaki K; Imaizumi H; Kida M; Iwai T; Yamauchi H; Kaneko T; Hasegawa R; Masutani H; Tadehara M; Adachi K; Watanabe M; Kurosu T; Tamaki A; Kikuchi H; Ohno T; Koizumi W
Dig Dis Sci; 2021 Dec; 66(12):4475-4484. PubMed ID: 33495919
[TBL] [Abstract][Full Text] [Related]
10. Frequent guidewire passage into the pancreatic duct is an independent risk factor for postendoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) among high-risk individuals: A post-hoc analysis of a randomized controlled trial data.
Goenka MK; Akshintala VS; Kamal A; Bhullar FA; Bush N; Kumar V; Chakraborty M; Gurakar M; Lakhtakia S; Talukdar R; Trikudanathan G; Khashab MA; Kalloo AN; Reddy DN; Sinha SK; Singh VK; Kochhar R
J Dig Dis; 2023; 24(6-7):427-433. PubMed ID: 37505932
[TBL] [Abstract][Full Text] [Related]
11. Positive correlation between pancreatic volume and post-endoscopic retrograde cholangiopancreatography pancreatitis.
Maruyama H; Shiba M; Ishikawa-Kakiya Y; Kato K; Ominami M; Fukunaga S; Otani K; Hosomi S; Tanaka F; Kamata N; Taira K; Nagami Y; Yamagami H; Tanigawa T; Watanabe T; Yamamoto A; Kabata D; Shintani A; Fujiwara Y
J Gastroenterol Hepatol; 2020 May; 35(5):769-776. PubMed ID: 31618801
[TBL] [Abstract][Full Text] [Related]
12. Relationship between papilla-related variables and post endoscopic retrograde cholangiopancreatography pancreatitis: A multicenter, prospective study.
Wang X; Zhao J; Wang L; Ning B; Zeng W; Tao Q; Ren G; Liang S; Luo H; Wang B; Farrell JJ; Pan Y; Guo X; Wu K
J Gastroenterol Hepatol; 2020 Dec; 35(12):2184-2191. PubMed ID: 32511794
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors for Post-Endoscopic Retrograde Pancreatography Pancreatitis: A Retrospective Chart Review in a Regional Hospital in Japan.
Shimamura T; Miyahara K; Takamori A; Hidaka H; Ito Y; Fujimoto S; Takedomi H; Tsuruoka N; Sakata Y; Eguchi Y; Node K; Noda T; Fujimoto K
Digestion; 2020; 101(5):557-562. PubMed ID: 31487723
[TBL] [Abstract][Full Text] [Related]
14. Chronic use of statins and risk of post-ERCP acute pancreatitis (STARK): Study protocol for an international multicenter prospective cohort study.
Korpela T; Cárdenas-Jaén K; Archibugi L; Poropat G; Maisonneuve P; Arcidiacono PG; De Pretis N; Löhr M; Capurso G; de-Madaria E
Dig Liver Dis; 2018 Dec; 50(12):1362-1365. PubMed ID: 30224317
[TBL] [Abstract][Full Text] [Related]
15. Pre- and post-procedure risk prediction models for post-endoscopic retrograde cholangiopancreatography pancreatitis.
Park CH; Park SW; Yang MJ; Moon SH; Park DH
Surg Endosc; 2022 Mar; 36(3):2052-2061. PubMed ID: 34231067
[TBL] [Abstract][Full Text] [Related]
16. Multicenter prospective cohort study of adverse events associated with biliary endoscopic retrograde cholangiopancreatography: Incidence of adverse events and preventive measures for post-endoscopic retrograde cholangiopancreatography pancreatitis.
Fujita K; Yazumi S; Matsumoto H; Asada M; Nebiki H; Matsumoto K; Maruo T; Takenaka M; Tomoda T; Onoyama T; Kurita A; Ueki T; Katayama T; Kawamura T; Kawamoto H;
Dig Endosc; 2022 Sep; 34(6):1198-1204. PubMed ID: 34963021
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic pancreatic duct stents reduce the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients.
Sofuni A; Maguchi H; Mukai T; Kawakami H; Irisawa A; Kubota K; Okaniwa S; Kikuyama M; Kutsumi H; Hanada K; Ueki T; Itoi T
Clin Gastroenterol Hepatol; 2011 Oct; 9(10):851-8; quiz e110. PubMed ID: 21749851
[TBL] [Abstract][Full Text] [Related]
18. The number of wire placement in the pancreatic duct and metal biliary stent as risk factors for post-endoscopic retrograde cholangiopancreatography pancreatitis.
Shin SH; So H; Cho S; Kim N; Baik GH; Lee SK; Park DH
J Gastroenterol Hepatol; 2020 Jul; 35(7):1201-1207. PubMed ID: 31830336
[TBL] [Abstract][Full Text] [Related]
19. Statin consumption and risk of post-endoscopic retrograde cholangiopancreatography pancreatitis.
Martínez-Moneo E; Cárdenas-Jaén K; Fernández-Laso AB; Millastre-Bocos J; Torralba-Gallego A; Martín-Arriero S; Alfaro-Almajano E; García-Rayado G; de-Madaria E
Pancreatology; 2020 Jul; 20(5):801-805. PubMed ID: 32448748
[TBL] [Abstract][Full Text] [Related]
20. Frequency of Post Endoscopic Retrograde Cholangiopancreatography Acute Pancreatitis in an Academic Hospital of Bangladesh.
Islam MS; Khalil MM; Hossain MI; Datta RK; Podder S; Khan ST; Ahmed F; Ahmed F; Rahman MM; Kibria MG
Mymensingh Med J; 2024 Jan; 33(1):133-139. PubMed ID: 38163784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
